داروسازی دکتر عبیدی

📈 Analytical overview of Telegram channel داروسازی دکتر عبیدی

Channel داروسازی دکتر عبیدی (@dr_abidipharma) in the Farsi language segment is an active participant. Currently, the community unites 32 918 subscribers, ranking 592 in the Medicine category and 10 764 in the Iran region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 32 918 subscribers.

According to the latest data from 14 October, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -17 over the last 30 days and by 0 over the last 24 hours, overall reach remains high.

• Verification status: Not verified
• Engagement rate (ER): The average audience engagement rate is 25.17%. Within the first 24 hours after publication, content typically collects 10.97% reactions from the total number of subscribers.
• Post reach: On average, each post receives 8 296 views. Within the first day, a publication typically gains 3 614 views.
• Reactions and interaction: The audience actively supports content: the average number of reactions per post is 65.
• Thematic interests: Content is focused on key topics such as داروسازی, کودک, معده, راهکار, دارو.

📝 Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
“🔹داروسازی دکتر عبیدی عضوی از گروه کوبل 🔸وب‌سایت: https://abidipharma.com/ 🔹اینستاگرام: https://www.instagram.com/dr_abidipharma 🔸بله: http://ble.ir/dr_abidipharmaceuticals 🔹آپارات: https://www.aparat.com/Abidiphar”

Thanks to the high frequency of updates (latest data received on 15 October, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.